Clinical and electrical performance of expanded polytetrafluoroethylene- covered defibrillator leads in comparison to traditional leads

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue 1, 2008, Pages 47-55

  Koplan, Bruce A ^a   Weiner, Stan ^b   Gilligan, David ^c   Thackeray, Lisa ^d   Merkel, Stacia ^d   Chase Berg, Kellie ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Tyler Cardiovascular Consultants   (United States)

^c Virginia Cardiovascular Specialists   (United States)

^d Integra Group   (United States)

^e Boston Scientific CRM   (United States)

Author keywords

Amplitude; Defibrillation lead; Defibrillation testing; Impedance; Implantable defibrillator; Shock conversion; Threshold

Indexed keywords

POLITEF;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; ELECTROPHYSIOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; RANDOMIZED CONTROLLED TRIAL;

AGED; CHI-SQUARE DISTRIBUTION; COATED MATERIALS, BIOCOMPATIBLE; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ELECTRODES, IMPLANTED; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; POLYTETRAFLUOROETHYLENE;

EID: 37648999733     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00924.x     Document Type: Article

References (17)

1. Lawton JS, Wood MA, Gilligan DM, Stambler BS, Damiano RJ, Jr., Ellenbogen KA. Implantable transvenous cardioverter defibrillator leads: The dark side. Pacing Clin Electrophysiol 1996 19 : 1273 1278.
2. Schwartzman D, Nallamothu N, Callans DJ, Preminger MW, Gottlieb CD, Marchlinski FE. Postoperative lead-related complications in patients with nonthoracotomy defibrillation lead systems. J Am Coll Cardiol 1995 26 : 776 786.
3. Nelson R, Gilman B, Shapland J, Lehmann MH. Leads for the ICD. In : Kroll M, Lehmann MH eds Implantable Cardioverter Defibrillator Therapy: The Engineering and Clinical Interface, Kluwer Academic Publishers, New York, 1996.
4. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007 115 : 2474 2480.
5. Robboy SJ, Harthorne JW, Leinbach RC, Sanders CA, Austen WG. Autopsy findings with permanent pervenous pacemakers. Circulation 1969 39 : 495 501.
6. Huang TY, Baba N. Cardiac pathology of transvenous pacemakers. Am Heart J 1972 83 : 469 474.
7. Byrd CL, Wilkoff BL. Techniques and devices for extraction of pacemaker and implantable cardioverter-defibrillator leads. In : Ellenbogen K, Kay GN, Wilkoff BL eds Clinical Cardiac Pacing and Defibrillation, W.B. Saunders Company, Philadelphia, 2000
8. Epstein AE, Anderson PG, Kay GN, Dailey SM, Plumb VJ, Shepard RB. Gross and microscopic changes associated with a nonthoracotomy implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1992 15 : 382 386.
9. Wilkoff BL, Belott PH, Love CJ, Scheiner A, Westlund R, Rippy M, Krishnan M, et al. Improved extraction of ePTFE and medical adhesive modified defibrillation leads from the coronary sinus and great cardiac vein. Pacing Clin Electrophysiol 2005 28 : 205 211.
10. Chan IS. Exact tests of equivalence and efficacy with a non-zero lower bound for comparative studies. Stat Med 1998 17 : 1403 1413.
11. Fleiss JL, Levin B, Paik MC. Statistical Methods for Rates and Proportions. Wiley-Interscience, Hoboken, NJ, 2003.
12. Pires LA, Johnson KM. Intraoperative testing of the implantable cardioverter-defibrillator: How much is enough? J Cardiovasc Electrophysiol 2006 17 : 140 145.
13. Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, et al. Inductionless or limited shock testing is possible in most patients with implantable cardioverter-defibrillators/cardiac resynchronization therapy defibrillators: Results of the multicenter ASSURE Study (arrhythmia single shock defibrillation threshold testing versus upper limit of vulnerability: Risk reduction evaluation with implantable cardioverter- defibrillator implantations). Circulation 2007 115 : 2382 2389.
14. Guidant Corporation. CONTAK RENEWAL System Guide. 2003.
15. Guidant Corporation. VITALITY AVT System Guide. 2003.
16. Medtronic. Marquis® Reference Manual. 2002.
17. St. Jude Medical. Atlas® System Guide. 2003.